Cargando…

Specifically targeting ERK1 or ERK2 kills Melanoma cells

BACKGROUND: Overcoming the notorious apoptotic resistance of melanoma cells remains a therapeutic challenge given dismal survival of patients with metastatic melanoma. However, recent clinical trials using a BRAF inhibitor revealed encouraging results for patients with advanced BRAF mutant bearing m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Jianzhong, Xin, Hong, Nickoloff, Brian J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305427/ https://www.ncbi.nlm.nih.gov/pubmed/22277029 http://dx.doi.org/10.1186/1479-5876-10-15

Ejemplares similares

Targeting the ERK Signaling Pathway in Melanoma
por: Savoia, Paola, et al.
Publicado: (2019)

Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis
por: Ricard, Nicolas, et al.
Publicado: (2019)

ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
por: Buscà, Roser, et al.
Publicado: (2016)

α-MSH-PE38KDEL Kills Melanoma Cells via Modulating Erk1/2/MITF/TYR Signaling in an MC1R-Dependent Manner
por: Liu, Xilin, et al.
Publicado: (2020)

Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
por: Shukla, Arti, et al.
Publicado: (2010)

ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1
por: Buscà, Roser, et al.
Publicado: (2015)

Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors
por: Lebedev, Timofey D., et al.
Publicado: (2022)

The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis
por: Guney, Gurhan, et al.
Publicado: (2022)

Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration during Mouse Embryonic Angiogenesis
por: Srinivasan, Ruchika, et al.
Publicado: (2009)

ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1
por: Balmanno, Kathryn, et al.
Publicado: (2023)

ERK mediates interferon gamma-induced melanoma cell death
por: Champhekar, Ameya, et al.
Publicado: (2023)

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma
por: Krepler, Clemens, et al.
Publicado: (2016)

Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells
por: Jin, Lei, et al.
Publicado: (2018)

LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway
por: Miao, Xiang, et al.
Publicado: (2021)

The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2
por: Marchi, Matilde, et al.
Publicado: (2008)

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
por: Sale, Matthew J., et al.
Publicado: (2019)

LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1
por: Chang, Shwu-Fen, et al.
Publicado: (2015)

The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
por: Wang, Zeyou, et al.
Publicado: (2016)

Aloin promotes cell apoptosis by targeting HMGB1-TLR4-ERK axis in human melanoma cells
por: Li, Pan, et al.
Publicado: (2020)

Activation of the SphK1/ERK/p-ERK pathway promotes autophagy in colon cancer cells
por: Xu, Chunyan, et al.
Publicado: (2018)

Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
por: Tomasovic, Angela, et al.
Publicado: (2020)

Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis
por: Luo, Xiangjian, et al.
Publicado: (2015)

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially
por: Vantaggiato, Chiara, et al.
Publicado: (2006)

ERK1 and ERK2 MAPK are key regulators of distinct gene sets in zebrafish embryogenesis
por: Krens, SF Gabby, et al.
Publicado: (2008)

Spatiotemporal Regulation of ERK2 by Dual Specificity Phosphatases
por: Caunt, Christopher J., et al.
Publicado: (2008)

TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation
por: Oberst, Michael D, et al.
Publicado: (2008)

Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines
por: Gusenbauer, Simone, et al.
Publicado: (2015)

ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
por: Cook, Simon J., et al.
Publicado: (2022)

Dimethyl Fumarate Combined With Vemurafenib Enhances Anti-Melanoma Efficacy via Inhibiting the Hippo/YAP, NRF2-ARE, and AKT/mTOR/ERK Pathways in A375 Melanoma Cells
por: Li, Hongxia, et al.
Publicado: (2022)

Xenoestrogen-Induced ERK-1 and ERK-2 Activation via Multiple Membrane-Initiated Signaling Pathways
por: Bulayeva, Nataliya N., et al.
Publicado: (2004)

MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway
por: Shen, Zhongyi, et al.
Publicado: (2019)

Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription
por: Honda, Takuto, et al.
Publicado: (2015)

miR-155 Inhibits Nucleus Pulposus Cells' Degeneration through Targeting ERK 1/2
por: Ye, Dongping, et al.
Publicado: (2016)

Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses
por: Jiang, Lin, et al.
Publicado: (2014)

Simultaneous Inhibition of the HGF/MET and Erk1/2 Pathways Affect Uveal Melanoma Cell Growth and Migration
por: Chattopadhyay, Chandrani, et al.
Publicado: (2014)

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
por: Liu, Szu-Mam, et al.
Publicado: (2014)

ERK1/2 in immune signalling
por: Lucas, Richard M., et al.
Publicado: (2022)

ERK5 is activated by oncogenic BRAF and promotes melanoma growth
por: Tusa, Ignazia, et al.
Publicado: (2018)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma
por: Hu, Huanrong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mdtl4g8icb3ealjpm50rsjmmk9